Similar Articles
921 Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model
922 Effects of interactions between environmental factors and KIF1B genetic variants on the risk of hepatocellular carcinoma in a Chinese cohort
923 Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study
924 Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma
925 High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation
926 Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma
927 Hepatocellular carcinoma: Review of disease and tumor biomarkers
928 Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma
929 Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein
930 Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA